Document 1820
 DOCN  M94A1820
 TI    Impact of socio-economic factors as adjuvant in AIDS-treatment. A follow
       up of 18 patients taking Retrovir.
 DT    9412
 AU    Minlangu M; Nzila M; Kapita B; Projet Sida/Kinshasa-Zaire, Antwerpen,
       Belgium.
 SO    Int Conf AIDS. 1994 Aug 7-12;10(1):444 (abstract no. PD0383). Unique
       Identifier : AIDSLINE ICA10/94370755
 AB    OBJECTIVES: To determine the role of the surroundings of african
       AIDS-patients. To demonstrate how economic problems could depress
       patients, and adopting a negative behavior. METHODS: Between 1988-1989,
       African AIDS-patients were recruited for Retrovir trial. All cases were
       selected and had to give a written consent associating a third person
       who was utilized as psychological adjuvant. The cohort is being followed
       up, until the last patient will died, by a physician and four nurses.
       They have been hospitalized for the first three weeks then assessed once
       a month or anytime problems occurred. RESULTS: 7 men and 11 women, 24-46
       years old, who had experienced already at least one of these
       opportunistic infections: candidiasis, herpes-zoster, TBC, pneumocytisis
       ..., etc ... were enrolled to a Retrovir trial. Evolution: 2/18 (11.1%)
       excluded, 2/16 (12.5%) was lost for follow up by refusing collaboration
       when the surroundings knew that they were HIV(+), 4/16 died before one
       year of follow up, 5/16 (31.8%) died in the second year, 5/16 (31.8%)
       overtopped 2 years amongst them 3 (18.8%) are still a live. 6/18 (33.3%)
       hastened their death by refusing collaboration after committing a breach
       of their confidences. 5/18 (27.8%) fell down consequently to the
       national economic depression. CONCLUSION: Whatever retrovir seem to
       ameliorate the general status, the surroundings are a lot of to do for
       improving of AIDS-patient health care.
 DE    Acquired Immunodeficiency Syndrome/*DRUG THERAPY/PSYCHOLOGY  Adult
       Cohort Studies  Female  Follow-Up Studies  Human  Male  Middle Age
       Social Support  Socioeconomic Factors  Zaire  Zidovudine/*THERAPEUTIC
       USE  CLINICAL TRIAL  MEETING ABSTRACT

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).